Literature DB >> 10699371

Alterations of Na(+) homeostasis in hepatocyte reoxygenation injury.

R Carini1, M G De Cesaris, R Splendore, M Bagnati, G Bellomo, E Albano.   

Abstract

Reperfusion injury represents an important cause of primary graft non-function during liver transplantation. However, the mechanism responsible for cellular damage during reoxygenation has not yet been completely understood. We have investigated whether changes in intracellular Na(+) distribution might contribute to cause hepatocyte damage during reoxygenation buffer after 24 h of cold storage. Hepatocyte reoxygenation resulted in a rapid increase in cellular Na(+) content that was associated with cytotoxicity. Na(+) accumulation and hepatocyte death were prevented by the omission of Na(+) from the incubation medium, but not by the addition of antioxidants. Blocking Na(+)/H(+) exchanger and Na(+)/HCO(3)(-) co-transporter by, respectively, 5-(N,N-dimethyl)-amiloride or omitting HCO(3)(-) from the reoxygenation medium significantly decreased Na(+) overload and cytotoxicity. Stimulation of ATP re-synthesis by the addition of fructose also lowered Na(+) accumulation and cell death during reoxygenation. A significant protection against Na(+)-mediated reoxygenation injury was evident in hepatocytes maintained in an acidic buffer (pH 6.5) or in the presence of glycine. The cytoprotective action of glycine or of the acidic buffer was reverted by promoting Na(+) influx with the Na(+)/H(+) ionophore monensin. Altogether, these results suggest that Na(+) accumulation during the early phases of reoxygenation might contribute to liver graft reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699371     DOI: 10.1016/s0925-4439(99)00114-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Effect of ischemia-reperfusion on bile canalicular F-actin microfilaments in hepatocytes of human liver allograft: image analysis by confocal laser scanning microscopy.

Authors:  L Benkoël; F Dodero; J Hardwigsen; P Campan; D Botta-Fridlund; D Lombardo; Y P Le Treut; A Chamlian
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

Review 2.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

3.  Effect of ischemia-reperfusion on Na+, K+-ATPase expression in human liver tissue allograft: image analysis by confocal laser scanning microscopy.

Authors:  Liliane Benkoel; Frank Dodero; Jean Hardwigsen; Eric Mas; Anne-Marie Benoliel; Danielle Botta-Fridlund; Yves Patrice Le Treut; Albert Chamlian; Dominique Lombardo
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

4.  Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition.

Authors:  Marisol Ruiz-Meana; Pilar Pina; David Garcia-Dorado; Antonio Rodríguez-Sinovas; Ignasi Barba; Elisabet Miró-Casas; Maribel Mirabet; Jordi Soler-Soler
Journal:  J Physiol       Date:  2004-06-24       Impact factor: 5.182

5.  Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiology.

Authors:  Kilian Weigand; Sylvia Brost; Niels Steinebrunner; Markus Büchler; Peter Schemmer; Martina Müller
Journal:  HPB Surg       Date:  2012-05-30

Review 6.  Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection.

Authors:  Muntasir Billah; Anisyah Ridiandries; Usaid Allahwala; Harshini Mudaliar; Anthony Dona; Stephen Hunyor; Levon M Khachigian; Ravinay Bhindi
Journal:  Oncotarget       Date:  2019-01-04

Review 7.  Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype.

Authors:  Elisa Alchera; Chiara Imarisio; Giorgia Mandili; Simone Merlin; Bangalore R Chandrashekar; Francesco Novelli; Antonia Follenzi; Rita Carini
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.